Medicamen Biotech signs CDMO agreement with Vital Pharma Nordic

Medicamen Biotech has entered into long term agreement with Vital Pharma Nordic, a Denmark based company, for CDMO for multiple products.

Vital Pharma Nordic is led by highly experienced specialists and engaged in licensing, development, distribution and sales of specialty Gx pharmaceuticals. VPN operate in the Nordic region now expanding internationally.

Powered by Capital Market - Live News